MedPath

AMARANTH MEDICAL INC.

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 2
4 (100.0%)

Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III)

Phase 2
Conditions
Myocardial Ischemia
Coronary Artery Disease
First Posted Date
2016-09-15
Last Posted Date
2016-11-25
Lead Sponsor
Amaranth Medical Inc.
Target Recruit Count
70
Registration Number
NCT02900937
Locations
🇨🇴

Clinica de Marly, Bogota, Colombia

🇨🇴

Instituto del Corazon, Bucaramanga, Colombia

🇨🇴

Angiografia De Occidente S.A., Cali, Colombia

and more 10 locations

Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent

Phase 2
Conditions
Myocardial Ischemia
Coronary Artery Disease
First Posted Date
2015-10-06
Last Posted Date
2016-06-08
Lead Sponsor
Amaranth Medical Inc.
Target Recruit Count
60
Registration Number
NCT02568462
Locations
🇨🇴

Clinica de Marly, Bogota, Colombia

🇨🇴

Instituto del Corazon, Bucaramanga, Colombia

🇨🇴

Angiografia De Occidente S.A., Cali, Colombia

and more 9 locations

Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent

Phase 2
Conditions
Coronary Artery Disease
Myocardial Ischemia
First Posted Date
2014-10-03
Last Posted Date
2016-06-08
Lead Sponsor
Amaranth Medical Inc.
Target Recruit Count
21
Registration Number
NCT02255864
Locations
🇮🇹

Azienda Policlinico-Vittorio Emanuele, Universita di Catania, Catania, Italy

🇮🇹

Ospedale San Raffaele, Milano, Italy

🇮🇹

A. O. U. Federico IIËš Policlinico, Napoli, Italy

and more 2 locations

Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent

Phase 2
Conditions
Coronary Artery Disease
Myocardial Ischemia
First Posted Date
2014-07-14
Last Posted Date
2016-06-08
Lead Sponsor
Amaranth Medical Inc.
Target Recruit Count
42
Registration Number
NCT02189499
Locations
🇨🇴

Clinica de Marly, Bogota, Colombia

🇨🇴

Instituto del Corazon, Bucaramanga, Colombia

🇨🇴

Angiografia De Occidente S.A., Cali, Colombia

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.